SGA expense really needs to go down!I wish they can cut SGA expenses from 13 million to about 8 million a year. That way, in 2022 we will have 21.2*0.91 = 19.3 m gross profit - 8 m SGA - 6 m R&D = 5.3 m operating income. If we do that, even without any growth thereafter, we should have a stable 53 million valuation which is $0.22 per share.